When ii heard the story of the death of little
Tanner Clements in May 2022 in Virginia County USA, as reported on the Hotbox
Show #224 ii was devastated, both for the child and for the plant. The purpose of this paper is to highlight the difference between
plant and synthetic THC medicine as well as to emphasize the high safety margin
of whole-herbal Cannabis medicine compared to synthetic THC drugs. It is very
important that people understand the difference and realize that you cannot
even compare plant medicine to the wicked synthetic medicines that are being produced
today, not only Cannabis medicines, all of them.
The story follows that the child consumed medicated
‘gummies’ containing synthetic THC. In this case Delta-8 THC was detected in
the child’s bloodstream. Although the plant does naturally produce this
cannabinoid, the amounts are so minimal that it is not worth extracting and
this is why people use synthetic Delta-8 THC which is just one of the 13 odd
analogues or versions of the THC molecule. Synthetic Delta-8 THC is known to
come with ‘serious health risks’ and contain various contaminants.
30 year old Dorothy Clements is the mother of
little Tanner and she was arrested for the murder and neglect of her child and
is apparently still sitting inside without ‘bail’ application being an option.
This terribly unfortunate event highlights the need for more education and an
even more urgent need for adult responsibility in the private home space.
How is it possible that a substance like plant-extracted
THC has almost no effect on small children?
Personally ii have been treating small children
with Cannabis medicine since the 1980’s when ii was still in high school.
Asthma, epilepsy, allergies, cancer...all the conditions and never in my life
have ii seen the plant harm a child. However, ii have seen a few cases where
the child has received too much THC, this is why it is so important to me that
at least one person in every household understands the workings of the ECS and
how to work with the plant.
If ii had stayed in the Babylon medical system ii
would most likely have specialised in paediatrics and ii really enjoyed my 6
months at Red Cross Hospital during my training, so ii have always been a keen
researcher of child medicine and ii am a huge fan of the solid research work of
Professor Ester Fride in the realm of Pediatric Cannabis Medicine research.
Professor Ester Fride Ph.D. passed away on 1
January 2010 age 56. She was the Dutch-born Israeli scientist who worked very
closely with Professor Mechoulam, and they shared a lab since the 1990’s. He
graced her with the title of Chairperson at the Department of Behavioural Sciences and the Department of Molecular Biology at The College of Judea and Samaria in Ariel Israel. She led and
co-authored over 66 published peer-reviewed scientific papers.
Thanks to her research we now know the following:
1. That the activation of our Cannabinoid receptors by our natural Endocannabinoids is crucial to the suckling response in new- born babies. [1]
2. That Endocannabinoids are naturally present in human breast milk. [2]
3. The Endocannabinnoid system (ECS) is implicated in the embryonic implantation process that is controlled by our Endocannabinoids known as Anandamide and 2-AG. This means that Cannabis and the ECS literally give us life! [3] [4]
4. That the ECS is critical to pre and post-natal brain development. [5] [6] [7]
5. That Endocannabinoids help to stimulate the tongue muscles, and treat various swallowing difficulties in adults and children with Cannabis medicine because the research results are so successful. [8]
6. That dose-controlled whole-herbal plantTHC has no adverse effects on small children because of the delayed expression of ECS receptors in early human development. [9] [10] [11]
7. That stress depletes the ECS, the ECS receptors as well as the endocannabinoids, in paticular Anandamide. [12] [13]
Professor Fride’s work proved that Cannabinoid receptors develop very slowly during the post-natal stage. This ties up with observations that small children appear to be insensitive to the psychoactive effects of controlled Cannabinoid treatment, and specifically to THC. Because of Professor Fride’s revelation, we now know that this gradual increase of EC system activity in the human body is accompanied by a gradual maturation in the response to the psychoactive properties of THC.
In studies of post-natal mice a gradual increase in
the density of THC receptors was recorded in the brain, and this led to the
important discovery that small children can benefit from Cannabis medicine
without any harsh side-effects. There are numerous studies from Hebrew University in Israel where
children between the ages of 3 and 13 undergoing chemotherapy were administered
high THC doses, approximately 0.64 mg/kg per treatment. Some of these children
were given doses for long periods of time, up to 114 treatments based on 4 treatments
per 24-hour period. The anti-emetic effects were also impressive with no real
side-effects at all. [9]
In another of her studies eight children between
the ages of 3 and 14 years with severe neurological damage were treated with
between 0.04 – 0.12 mg/kg per day.
Across the board, improvements in behaviour included reduced spasticity,
improved dystonia (muscle movements), increased interest in surroundings and
anti-epileptic activity, all with no notable side-effects. This same study
included the case of an 11-year-old girl, who, after a motor accident suffered
a spinal contusion with total paraplegia and a frontal skull fracture. The
patient suffered from posttraumatic stress disorder, mood disturbances and lack
of appetite. The daily THC dose administered improved her appetite and mood, as
well as her spasticity, with no side-effects. [10]
“Noteworthy, fully functional eCB
system does not seem to emerge until adulthood, as acute challenge of mouse
pups with AEA (20 mg/kg i.p.) does not produce anticipated analgesia and motor
depression (Fride and Mechoulam, 1996).
This outcome could be explained by the fact that effects of CB challenge require complex interplay between several components of eCB system that are only reaching their final levels and patterns of distribution in adulthood Lee et al., 2016)” [10]
Over the past twenty years we have seen such excellent clinical results from Cannabis treatment in small children and young adults, especially in paediatric oncology and neurology conditions, where children have been suffering from serious neurological conditions and brain trauma such as epilepsy. All of these healings become possible because of the now scientifically proven fact that cannabinoid receptor expression is different in children.
It is interesting to learn that only a temporary
presence of receptors is expressed during development, but not during
adulthood, in certain regions of the brain at the Corpus Callosum and the
anterior commissure, which connects the neuronal pathways between the left and
right hemispheres of the brain. These expressions were studied between
gestational day 21 and post-natal day 5, and this proves the important role of
cannabinoids in human brain development. [12]
In my opinion this natural paediatric expression of
the human ECS is so clearly and so obviously designed to be a biologically
adaptive defence mechanism designed to protect children from illness because
children are not supposed to be ill.
What about Human studies?
In her human studies Professor Ester confirmed the
results of past studies where cannabinoid receptors were identified in the
human embryo at week 14 of gestation.
In the 20th week of gestation in the
human embryo a selective (lesser) expression of the receptors was identified in
the hippocampus compared with a much wider expression in the adult human brain.
An advanced increase in the concentration of these cannabinoid receptors was
found in the frontal cortex, hippocampus, basal ganglia and cerebellum between
the foetal period and adulthood.
This proves that these receptors are functionally
active at all stages of human development. So, in other words, the receptor
concentration in these parts of the brain increased progressively only as the
human progressed and grew. We can clearly see how nature has accommodated small
children by ensuring only progressive development of the highly evolved ECS.
The most important finding was that the psychoactive effects of cannabinoid
treatment are virtually absent, or extremely reduced, in children (in
controlled studies) and now we know that this is because of the lower
concentrations of the actual receptors at younger ages.
Every day we hear miraculous stories of what
Cannabis can do for children, especially in respect of many types of cancers,
epilepsy and autism. It was Professor Fride’s studies that revealed that the
human version of THC, Anandamide, displayed a neuro-protective role in the
post-natal brain. The fact that our Cannabis receptors are present in the white
matter regions of the pre-and post-natal nervous system proves that the ECS
plays a specific role in early brain development. Throughout our lives from
conception to the end of life THC is required to ensure healthy human brain
development. This is why we need the Cannabis plant in our daily lives.
Why is whole-plant Cannabis medicine so safe?
There are three main reasons why whole-plant Cannabis medicine as opposed to laboratory produced synthetic versions is so safe that it has never ever killed a single human being. The same cannot be said about the dangerous synthetic medicines that doctors are forced to prescribe instead of the actual plant. We have just looked at the work of Professor Fride who proved that THC does not harm small children because of the delayed and reduced expression of ECS receptors in early life.
The second reason is that the active component of the plant, THC only acts as a partial agonist of the ECS receptors. And thirdly, the reason why no one has ever overdosed from Cannabis and the biological reason why no one has ever died from Cannabis, is because there are no ECS receptors on the cardiac and respiratory cells in the brain stem.
In June 2003 a paper titled “Cannabis and the brain” was published in Volume 126 of the Brain
Journal that confirms that the ‘relative absence of the cannabinoid
receptors from brainstem nuclei accounts for the low toxicity of cannabinoids
when given in overdose.”
Properly prescribed Cannabis plant medicine is the safest medicine in the world and it is so important to make sure that you know who made your medicine and what exactly is in the mix that you will put into your body. Better yet, make your own medicine because people have been self-medicating with this medicine for thousands of years already including treating their children.
The reason why there is such an increase in emergency room admissions, and even a few fatalities for Cannabis toxicity, is purely because of synthetic cannabis products
This increase in admissions, a far greater
percentage, now 15%, involve severe psychotic episodes brought about by the
extreme potency of these synthetic substances that the human body was not
designed to consume.
It’s exactly like Ras Warren stated on the Hotbox Show #224, it really feels like governments and corporations worldwide have been trying to pin the death and schizophrenia tail on the ‘dagga-donkey’ for way too long now and it almost seems like they are desperate to proclaim the ‘first death by cannabis’ to the world.
The world must be educated in the severe differences between plant and synthetic Cannabis products and the dangers of the side-effects.
The most important difference between plant and synthetic medicine is that plant medicine acts as a partial agonist at its target. This means that these medicines only have partial efficacy at the receptors that they bind to and this is in respect of children and adults. For example, the chief chemical component of Cannabis is THC (Tetrahydrocannabinol, Delta 9 THC) and THC only acts as a partial agonist at the ECS receptors.
On the other hand, synthetic THC will work as a FULL AGONIST at the ECS receptors. This means that synthetic THC is far more potent than plant THC, around 800 times, if you can believe that there are no limits to the extreme behaviour of the beast that is corporate medicine. In the 2021 scientific paper led by Dr Vidyasagar Bukke, titled “Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health”, the authors unashamedly announce that
“-it is believed
that synthetic cannabinoids are 800 times more potent than Cannabis.”
Not only are the effects of fake Cannabis much more
intense, the crash or ‘come-down’ of these fake products is also a big concern and
we will most likely continue to see an increase in emergency room admissions.
This is because of the known medical fact that synthetic THC drugs are
associated with severe negative psychiatric and medical symptoms. This is a
very important piece of information and the very reason for the high safety
margin of whole herbal Ganja medicine. Quite frankly reading statements like
this make my brain and eyes bleed into my heart for how is it even possible to
get away with these actions? Synthetic cannabinoids should be banned off the
face of the Earth and the scientists should be arrested for murder because for
the first time in the history of mankind we are now starting to see people
dying from using synthetic Cannabis products designed to kill people and this
in turn demonizes the actual plant. [14] [15] [17]
In another published scientific paper, Cohen and
Weinstein 7 June 2018, that you can find on this site https://www.frontiersin.org/articles/10.3389/fpubh.2018.00162/full the scientists opened their
paper with the following statement:
“Synthetic
cannabinoid products have effects similar to those of natural cannabis, yet,
these drugs are more potent and dangerous, and have been associated with
dangerous adverse effects. These synthetic drugs replicate the effects of
natural cannabis and Δ9-tetrahydrocannabinol but they induce more severe
adverse effects including respiratory difficulties, hypertension, tachycardia,
chest pain, muscle twitches, acute renal failure, anxiety, agitation,
psychosis, suicidal ideation, and cognitive impairment. Chronic use of
synthetic cannabinoids has been associated with
serious psychiatric and medical conditions and even death.” [16] [17] [18] [19]
The
biggest problem with these products is that they contain no CBD to provide any
assistance to the patient because it can be very difficult to control the dose
of synthetic THC drugs. Oftentimes patients have no choice but to commit to the
extreme potency and the sad side-effects of these synthetic THC products. The
THC and CBD ratios must be aligned naturally otherwise the medicine will not be
effective in calming the effects of the synthetic THC. [20] [21] [22] [23] [24]
[25]
The
second biggest problem with synthetic THC is that these products contain a wide
range of highly-potent full agonists that mimic ‘THC-like’ effects, except that
they are far more severe and can last for weeks. This will never ever happen
when consuming the actual Cannabis plant. [24] [25] [26] [27] [28] [29] [30] [31]
[32] [33] [34] [35] [36] [37] [38] [39] [40]
Cannabis
is known to induce psychotropic effects like euphoria, calm, relaxation, and an
overall pleasant feeling that you will never achieve with synthetics that are
riddled with toxins and severe side-effects
When
you use synthetic THC drugs produced by the pharmaceutical industry you will
look forward to some pretty undesirable effects like nausea and vomiting, severe
agitation, irritability, confusion, tachycardia, anxiety, high blood pressure, seizures,
heavy hallucinations accompanied by delusions, psychosis with depression and
suicidal thoughts, and even death. [41]
[42] [43]
You simply cannot compare synthetic THC medicine
with organic Cannabis extracts
The third problem with synthetic THC medications,
and even the synthetic CBD products, they just aren’t as effective as the plant.
There are three reasons for this fact. First is the botanical concept of “the
entourage effect” that dictates that all of the plants’ components are required
in order to achieve true healing. The second reason is because the ECS does not
recognize synthetic cannabinoids. The body is unable to break them down and
they end up staying in the patient’s body for long periods of time wreaking
havoc in the already diseased body. Dr Ware of Health Canada, He says:
“By
virtue of purifying those resins, isolating them, and putting them into
pharmaceutical products, you sort of give rise to a more standardized and clean
product…the challenge is that even though we have these existing prescription
cannabinoids that these prescription medicines don’t seem to work the same
way that the herbal product does.”
Another
reason why synthetic Cannabis medications are not as effective as the plant is because
they are loaded with all sorts of extra ingredients that in themselves are
toxic like preservatives, additives, fatty acids, amides, esters,
benzodiazepines and substances that are even included in opioids like Tramadol.
You
have to ask yourself why would anyone want to destroy this perfectly natural
medicine that works flawlessly without any intervention from mankind by adding
all these extra toxins? Believe it or not, some people say that they are
probably added to these drugs intentionally to ensure a greater psychoactive
effect and to act as ‘masking agents’ to cause confusion in identifying the
main psychoactive substances within in these dangerous designer drugs being
forced onto people today.
Scientists
Zuba and Byrska in their 2013 paper “Prevalence and co-existence of active
components of ‘legal highs’ revealed the following about 449 samples:
“The most common ingredients of legal highs
were (in descending order): MPDV, caffeine, butylone, TFMPP, lidocaine, 4-MEC,
mephedrone, pFPP, BZP, and MDPBP. The scatter of substances changed over time,
and piperazines were often ousted by cathinones. Most of the preparations were
composed of two or more ingredients. Cathinones and piperazines were mixed
mainly within the chemical classes (77.6% and 56.1% of dual links,
respectively), caffeine was mixed both with piperazines (24 products) and
cathinones (22 products), whereas lidocaine only with the latter class (47
products).”
Most of these ingredients are synthetic
psychedelics, anesthetics, synthetic amphetamine stimulant drugs and other
illicit recreational drugs that are masquerading as natural plant Cannabis
medicine. In my opinion this is the ultimate form of deceit and reminds me of
the biblical scripture in the Revelation 18 verse 23. [44] [45] [46]
Doctors and psychiatrists and nursing staff
need to be educated in the ECS and how plant medicine naturally heals the body without
disastrous side-effects. All of these implications need to be seized by medical
schools and all medical training facilities, especially those who profess to care
about community child-health or adolescent medicine. Doctors need to be
introduced to the whole herbal plant and not only the dangerous synthetics that
they will be allowed to sell.
The most
disturbing observation of these fake Cannabis products is the extreme level of
aggression and violence we are observing with its use. This together with the
fact that these synthetic THC drugs are highly addictive is a huge red flag on
the mental health safety radar, but it seems that no one is even watching.
Parents have been
struggling for decades to obtain natural Cannabis medicine to cure their
children’s illnesses. Charlotte Caldwell, mother of little Billy who suffers
with severe epilepsy, had to leave Northern Ireland to go to America to help
her son and then deal with the Minister of Medicine to issue an emergency
licence for her son’s treatment. It should never ever be so hard to use a plant
to cure an illness.
Hannah Deacon also
struggled for many years to treat her son Alfie who also suffers from epilepsy.
Finally in 2018 she was able to bring in only 5 months of treatment into the UK
from Amsterdam. Meanwhile Sophia Gibson a young child with Dravets syndrome and
awaiting her medical licence was recently hospitalised and placed on
life-support because she so desperately needs this medicine. No one should ever
have to suffer like this to help their sick children.
And now a young mother in Virginia USA is
facing life imprisonment for the murder of her 4 year old son who died from
consuming synthetic Cannabis products. In my opinion she should be suing someone
for complete medical malpractice in the supply of dangerous drugs to the
population. I spent a lot of time reading all the different media reports on
this case. In my opinion all evidence seems to indicate that 30 year old mom of
Tanner, Dorothy Clements, had the full intention of purchasing CBD gummies from
the shop in Fredericksburg near her hometown where she had clearly purchased
from before. All the media reports are laden with confusing journalism that
required me to thoroughly analyse all the information available.
Dorothy had been treating her little boy for
a known cardiac condition with CBD, but in a strange twist of events, the
police found an empty jar of THC gummies and everyone automatically assumed
that the little boy had eaten the whole jar because of the high levels of
synthetic Delta-8 THC in his blood.
On Saturday 5 November we celebrated National
Children’s Day here in South Africa, and it got me thinking that if a child has
to pass away in my country because of Cannabis irresponsibility then ii
guarantee you that it won’t be too long and the government will most likely
repeal the Privacy Bill in its entirety and believe me brothers and sisters...the
corporate pharmaceutical world is looking for such an opportunity to seize
total control; let us not give it to them at the cost of a child’s life. Let us
be woke and treat Ganja with the respect it deserves as a medicine and not a
party drug.
We can never ever allow this to happen so
please people pack away the irresistible and tempting edibles that will also be
so attractive to children and let us assume an air of responsible adulting and
responsible Cannabis use by refusing to ever allow synthetic Cannabis medicines
into your home. We also need to be mindful of the fact that today’s Ganja is so
much stronger than back in the 1960’s when 6% was considered high THC! The
quest for higher THC has led to far less plant-CBD and we must be conscious of
the consequences of these breeding practices and the effects of extremely high
THC on human mental health.
It is known that the ‘big pharma’ wishes to
ensure that in the future all prescription Cannabis medicine will be synthetic,
simply to continue their medical monopoly by keeping people sick. This will
also remove the need for actual plants to produce these life-threatening drugs
and this should be a huge concern to any conscious person.
Respect
the plant ~ Respect yourself
CITATIONS:
[1] (Fride et al, April 2005) “Endocannabinoids and food intake: newborn
suckling and appetite regulation in adulthood” Journal Experimental Biology and
Medicine Volume 230 Issue 4 pages 225-34 April 2005 PMID: 15792943
[2] (Fride E, 1
October 2004) “The Endocannabinoid – CB1 receptor system in pre-and postnatal
life”. Journal European Journal of Pharmacology Issue 500 Volume 1-3 pages
289-97 PMID: 15464041
[3] (Ester Fride
and Esther Shohami, 28 October 2002) “The Endocannabinoid System: function in
survival of the embryo, the newborn and the neuron”. Journal NeuroReport Volume
13 Issue 15 pages 1833-41 PMID: 12395075
[4] (Fride E, 1
October 2004) “The Endocannabinoid – CB1 receptor system in pre-and postnatal life”.
Journal European Journal of Pharmacology Issue 500 Volume 1-3 pages 289-97
PMID: 15464041
[5] (Fride E, 1
October 2004) “The Endocannabinoid – CB1 receptor system in pre-and postnatal
life”. Journal European Journal of Pharmacology Issue 500 Volume 1-3 pages
289-97 PMID: 15464041
[6] (Fride E, 25
February 2004) “The Endocannabinoid-CB receptor system: Importance for
development and in pediatric disease.” Journal Neuro Endocrinol Lett 25
February 2004 Volume 1-2 Issue 24-30 PMID: 15159678
[7] (Ester Fride,
February 2002) “Endocannabinoids in the central nervous system-an overview) Journal
Prostaglandins Leukot Essent Fatty Acids Volume 66 Issue 2-3 pages 221-33
PMID: 12052038
[8] (Proff Ester Fride, December 2003)
“The Endocannabinoid-CB Receptor System: Importance for
development and in paediatric disease” Journal Neuro Endocrinol Lett Volume
25 Issue (1-2) pages 24-30 PMID: 15159678
[9] (Abrahamov et al 1995) “An Efficient New
Cannabinoid Antiemetic in Paediatric Oncology”. Journal Life Science
1995 Volume 56 Issue 23-24 pages 2097-10276837. PMID 7776837
[10]
Maternal stress (Mechoulum R and Fride E, march 1996) “Developmental aspects of
Anandamide: Ontogeny of response of prenatal exposure”. Journal
Psychoneuroendocrinology Volume 21 Issue 2 pages 157-72
[11]
(Fride et al, 2009) “The
Endocannabinoid System during development: emphasis on perinatal events and
delayed effects”. Journal Vitamins and Hormones Volume 81 30 July 2009 pages
139-58 PMID 19647111
[12] (R. Mechoulam et al September 1996). “Endogenous
cannabinoid ligands — chemical and biological studies” Journal of Lipid
Mediators and Cell Signalling Volume 14 Issue 1-3 (45-49)
[13]
Maternal stress (Mechoulum R and Fride E, March 1996) “Developmental aspects of
Anandamide: Ontogeny of response of prenatal exposure”. Journal
Psychoneuroendocrinology Volum 21 Issue 2 pages 157-72
[14] (Pal Pacher and George Kunos,
May 2013) “Modulating the Endocannabinoid System in Human Health and Disease:
successes and failures”. The FEBS Journal Volume 280 Issue 9 Pages
1918-1943. PMCID: PMC368 NIHMSID: NIHMS5460242 PMID: 23551849
[15] (Carol A
Paronis et al December 2012)
“Tetrahydrocannabinol Acts as Partial Agonist/Antagonist in Mice”. Journal
Behavioural Pharmacol Volume 23 Issue 28 pages 802-5 PMID: 23075707 PMCID:
PMC3697741
[16] (Cohen K and
Weinstein AM, 7 June 2018) “Synthetic and Non-Synthetic Cannabinoid Drugs and
Their Adverse Effects-A Review from Public Health Prospective” Journal
Frontiers in Public Health Volume 6 Issue 162 PMID: 29930934 PMCID: PMC5999798
[17] (Castaneto MS, et al, 2014) “Synthetic cannabinoids:
epidemiology, pharmacodynamics, and clinical implications”. Journal Drug
Alcohol Depend Volume 144 Issue 12–41
[18] (Spaderna M, Addy PH and D'Souza DC, 2013) “Spicing things up: synthetic
cannabinoids”. Journal
Psychopharmacology Volume 228 pages 525–40.
[19] (Cohen K, and Weinstein A, 2018) “The effects of cannabinoids on
executive functions: evidence from cannabis and synthetic cannabinoids—a
systematic review.” Journal Brain Science Volume 8 Issue 40
[20] (Van
Amsterdam J, Brunt T and Van den Brink W, 2015) “The
adverse health effects of synthetic cannabinoids with emphasis on
psychosis-like effects.” Journal
Psychopharmacology Volume 29 pages 254-63
[21]
(Fattore L, 2016) “Synthetic
cannabinoids—further evidence supporting the relationship between cannabinoids
and psychosis”. Journal Biological
Psychiatry Volume 79 pages 539–48.
[22] (Burns JK,
2012) “Pathways from cannabis to psychosis: a
review of the evidence.” Journal Front Psychiatry Volume 4 Issue 128
[23] (Vallersnes
OM, et al, 2016) “Psychosis associated with acute recreational drug toxicity: a
European case series” Journal BMC Psychiatry Volume 16
page 293
[24]( Weinstein
AM, Rosca P, Fattore L and London ED, 2017) “Synthetic
cathinone and cannabinoid designer drugs pose a major risk for public health.” Journal Front
Psychiatry Volume 8 Issue 156
[25] (Seely
KA, Lapoint J, Moran JH and Fattore L, 2012) “Spice drugs are more than harmless herbal blends: a review of
the pharmacology and toxicology of synthetic cannabinoids.” Journal Progressive NeuroPsychopharmacol Biological
Psychiatry Volume 39 pages 234–43
[26] (Fattore
L, 2016) “Synthetic cannabinoids—further
evidence supporting the relationship between cannabinoids and psychosis.” Journal Biol Psychiatry Volume 79 pages 539–48
[27] (Palamar
JJ, Acosta P, 2015) “Synthetic cannabinoid
use in a nationally representative sample of US high school seniors.” Journal Drug Alcohol Depend. Volume 149 pages 194–202.
[28] (Cottencin
O, Rolland B, Karila L, 2013) “New designer
drugs (synthetic cannabinoids and synthetic cathinones): review of literature.” Journal Current Pharmacological Design Volume 20
pages 4106–11
[29] (Di
Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, et al, 2015) “ Proportion of patients in south London with first-episode psychosis
attributable to use of high potency cannabis: a case-control study.” Journal Lancet Psychiatry Volume 2
pages 233–8.
[30] (Fattore
L, Fratta W., 2011) “Beyond THC: the new
generation of cannabinoid designer drugs.” Journal
Front
Behav Neurosci. Volume 5
[31]
(Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V,
2013) “Acute toxicity due to the confirmed
consumption of synthetic cannabinoids: clinical and laboratory findings.” Journal Addiction Volume 108 pages 534–44
[32] (Morrison
PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al, 2009) “The acute effects
of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and
cognitive functioning.” Journal Psychol Med. Volume 39:1607–16
[33] (Lorenzetti
V, Solowij N, Yücel M, 2015) “The role of
cannabinoids on neuroanatomical alterations in cannabis users.” Journal Biol Psychiatry Volume 79 pages 17–31
[34] (Castellanos
D, Singh S, Thornton G, Avila M, Moreno A, 2011) “Synthetic cannabinoid use: a case series of adolescents.” Journal Adolesc Health Volume 49 pages 347–9
[35] (Crippa
JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al, 2009) “ Cannabis and anxiety: a critical review of the evidence.” Journal Human Psychopharmacol. Volume 24
pages 515–23
[36] (Altintas M, Inanc L, Oruc GA,
Arpacioglu S, Gulec H, 2016) “Clinical characteristics of synthetic
cannabinoid-induced psychosis in relation to schizophrenia: a single-center
cross-sectional analysis of concurrently hospitalized patients.” Journal
Neuropsychiatr Dis Treat. Volume 12 page
1893
[37] (Bambico FR, Nguyen NT, Katz N, Gobbi G, 2010) “Chronic exposure to cannabinoids
during adolescence but not during adulthood impairs emotional behaviour and
monoaminergic neurotransmission.” Journal Neurobiol Dis. Volume 37 pages 641–55
[38] (Renard J, Krebs MO, Jay TM, Le Pen G, 2013) “Long-term cognitive impairments
induced by chronic cannabinoid exposure during adolescence in rats: a strain
comparison.”
Journal Psychopharmacology Volume 225 pages 781–90
[39] (Khan M, Pace L, Truong A,
Gordon M, Moukaddam N, 2016) “Catatonia secondary to synthetic cannabinoid
use in two patients with no previous psychosis.” Journal
Am J Addict. Volume 25 pages
25–7.
[40] (Hall W, Degenhardt L, 2009) “Adverse
health effects of non-medical cannabis use.” Journal
Lancet Volume 374 pages
1383–91.
[41] (Hermanns-Clausen M, Kneisel S,
Szabo B, Auwärter V, 2013) “Acute toxicity due to the confirmed consumption
of synthetic cannabinoids: clinical and laboratory findings.”
Journal Addiction
Volume 108 pages 534–44
[42] (Mir A, Obafemi A, Young A, Kane C, 2011) “Myocardial infarction
associated with use of the synthetic cannabinoid K2.” Journal Pediatrics Volume 128 pages 1622–7
[43] (Schaefer N, Peters B, Bregel D, Kneisel S, Auwärter V,
Schmidt PH, et al, 2013) “A fatal case involving several
synthetic cannabinoids.” Journal Toxichem Krimtech Volume 80 pages 248–51
[44] (Fattore L, 2016) “Synthetic
cannabinoids-further evidence supporting the relationship between cannabinoids
and psychosis.” Journal Biological Psychiatry Volume 79 pages 539-48
[45] (Fattore L and Fratta
W, 2011) “Beyond THC: the new generation of cannabinoid designer drugs.”
Journal Frontiers Behavioral Neuroscience Volume 5 Issue 60
[46] (Zuba D and Byrska B,
2013) “Prevalence and co-existence of active components of ‘legal highs”.
Journal Drug Test Anal Volume 5 pages 420-9
